UNS Share Price

Open 0.06 Change Price %
High 0.06 1 Day 0.00 0.00
Low 0.05 1 Week 0.01 20.00
Close 0.06 1 Month 0.01 20.00
Volume 514826 1 Year -0.12 -66.67
52 Week High 0.30
52 Week Low 0.04
UNS Important Levels
Resistance 2 0.07
Resistance 1 0.07
Pivot 0.06
Support 1 0.05
Support 2 0.05
ASX Australia Most Active Stocks
AGO 0.05 0.00%
AGO 0.05 0.00%
AGO 0.05 0.00%
DUE 2.92 -0.34%
DUE 2.92 -0.34%
AYR 0.01 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RER 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
POH 0.03 50.00%
GPP 0.03 50.00%
PMQ 0.03 50.00%
HAO 0.14 40.00%
HAO 0.14 40.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
SGU 0.05 -37.50%
SGU 0.05 -37.50%
SGU 0.05 -37.50%
EXG 0.02 -33.33%
More..

Unilife Corp (ASX: UNS)

UNS Technical Analysis 2.5
As on 19th Jan 2017 UNS Share Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.10 & Strong Buy for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
UNS Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
UNS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.unilife.com
UNS Address
UNS
250 Cross Farm Lane
York, PA 17406
United States
Phone: 717-384-3400
Fax: 717-384-3401
UNS Latest News
Stock Mounting Higher in Afternoon Session: Unilife Corporation (NASDAQ:UNIS)   Wall Street Beacon   - 18th Jan 17
Honing in on Shares of Unilife Corporation (NASDAQ:UNIS)   Prospect Journal   - 17th Jan 17
Bragar Eagel & Squire, P.C. Is Investigating Unilife Corporation (NASDAQ:UNIS ...   Business Wire (press release)   - 14th Jan 17
Unilife Appoints Rosemary Crane and Duane DeSisto to its Board of Directors ...   PR Newswire (press release)   - 31st Oct 16
Unilife Corp. (UNIS) Issues Accelerated Convertible Note to Amgen   StreetInsider.com   - 24th Oct 16
Unilife Announces Filing of 2016 10-K   PR Newswire (press release)   - 24th Oct 16
Unilife Corp. (UNIS) Names New CEO; Updates on Cost Reduction Initiatives ...   StreetInsider.com   - 28th Jul 16
Unilife Corporation to Postpone Earnings Conference Call for Fiscal Year 2016 ...   PR Newswire (press release)   - 09th May 16
Unilife Corp. (UNIS), Amgen (AMGN) Extend Exclusivity Period; Unilife ...   StreetInsider.com   - 16th Feb 16
News Unilife Corp.UNIS   Wall Street Journal   - 11th Feb 11
Interactive Technical Analysis Chart Unilife Corp ( UNS ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Unilife Corp
UNS Business Profile
Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The company offers Unifill Syringe, a staked (fixed) retracting needle that is designed for use with liquid stable drugs; Unifill Select for use of liquid stable drug or vaccine, or a diluent to reconstitute and deliver a lyophilized drug supplied in a vial; and Unifill Assure, a finger flange and a thumb press for the intuitive self-injection of biologics. It also provides Rita disposable auto-injector that is designed to inject the prefilled dose from a single Unifill syringe; and Lisa reusable auto-injector, which automates the removal of the needle shield and enhances needle insertion and retraction, as well as EZMix dual or multi-chamber prefilled syringe for the reconstitution and delivery of injectable therapies. In addition, the company offers the Ocu-ject, a device for the delivery of microliter sized doses of drugs; and Depot-ject, a device that is designed to enable the precise placement of a drug depot into the vitreous of the eye, as well as Micro-ject, a device for optimizing the delivery of drugs with microliter doses that are unsuited to conventional device technologies. Its customers include pharmaceutical and biotechnology companies. The company is headquartered in York, Pennsylvania.